Buprenorphine And Naloxone Tablet
Product Images NDC 67296-2164

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-2164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of Buprenorphine hydrochloride, showing the molecular arrangement including hydroxyl, methoxy, and cyclopropyl groups along with the hydrochloride component as part of the compound.*

FDA Label Image

Chemical Structure (Buprenorphine 02)

Chemical structure of Buprenorphine, shown as a molecular diagram with labeled functional groups including hydroxyl, carbonyl, and an alkene side chain, along with associated hydrochloride dihydrate (HCl • 2H2O) notation.*

FDA Label Image

Image (Buprenorphine 03)

An instructional line drawing showing a person's open mouth with a finger placing a sublingual tablet under the tongue, illustrating the method of administering a sublingual tablet.*

FDA Label Image

Principal Display Panel (2 mg/0.5 mg Tablet Bottle Label)

Label for Buprenorphine and Naloxone Sublingual Tablets, USP 2 mg/0.5 mg by Redpharm Drug. The label includes instructions for pharmacists to dispense the Medication Guide, warnings about accidental ingestion by children, and storage conditions at 20 to 25°C. The package contains 30 tablets for sublingual use, with dosage details and NDC 42858-601-03.*

FDA Label Image

Principal Display Panel (8 mg/2 mg Tablet Bottle Label)

Label for Buprenorphine and Naloxone Sublingual Tablets, USP, 8 mg/2 mg strength, by Redpharm Drug. The label indicates the tablets are prescription-only, with a pack size of 30 tablets. Storage instructions recommend room temperature, 20° to 25°C (68° to 77°F). Additional details include a pharmacist dispensing note, warnings for accidental ingestion, and a barcode. The label also notes controlled substance information and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.